1. Home
  2. WSFS vs HAE Comparison

WSFS vs HAE Comparison

Compare WSFS & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WSFS Financial Corporation

WSFS

WSFS Financial Corporation

N/A

Current Price

$78.60

Market Cap

4.2B

Sector

Finance

ML Signal

N/A

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

N/A

Current Price

$105.22

Market Cap

3.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WSFS
HAE
Founded
1980
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.8B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
WSFS
HAE
Price
$78.60
$105.22
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$76.20
$84.13
AVG Volume (30 Days)
303.6K
851.1K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
1.12%
N/A
EPS Growth
15.42
N/A
EPS
3.26
0.72
Revenue
$963,949,000.00
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.40
$5.23
P/E Ratio
$24.12
$148.06
Revenue Growth
50.18
N/A
52 Week Low
$49.92
$47.32
52 Week High
$82.94
$109.57

Technical Indicators

Market Signals
Indicator
WSFS
HAE
Relative Strength Index (RSI) 40.73 76.00
Support Level $77.08 $79.52
Resistance Level $79.13 N/A
Average True Range (ATR) 1.14 2.69
MACD -0.49 0.88
Stochastic Oscillator 26.45 85.29

Price Performance

Historical Comparison
WSFS
HAE

About WSFS WSFS Financial Corporation

WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: the WSFS Bank segment provides loans and leases, and other financial products to commercial and consumer customers; the Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and the Wealth and Trust segment provides a broad array of planning and advisory services, investment management, trust services, and credit and deposit products to individual, corporate, and institutional clients. The majority of revenue is generated from the WSFS Bank segment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: